Sally Amanuel

Sally Amanuel has an extensive career in regulatory affairs and clinical delivery, with experience at various pharmaceutical and clinical research companies. Currently serving as President at PrimeVigilance Ltd., Sally previously held positions such as Head of Regulatory Affairs and Clinical Delivery at ERGOMED PLC and Senior VP at Worldwide Clinical Trials, Inc. Sally has a strong educational background with a Master of Business Administration from the University of Liverpool, a Master's Degree in Biotechnological Law and Ethics from The University of Sheffield, and a Bachelor's Degree in Biotechnology from UCL.